Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Congenital triangular alopecia is a harmless, non-spreading hair loss condition often seen in young children.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata treatment varies, with no optimal method established yet.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Removing the thymoma improved the man's autoimmune conditions.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.